Magnetic resonance imaging and ultrasound fusion biopsy in follow-up of patients in active surveillance protocol. Can PSA density discriminate patients at higher risk of reclassification?
2020 ◽
Vol 18
(6)
◽
pp. e698-e704
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 201
(1)
◽
pp. 84-90
◽
Keyword(s):